Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus

NCT04272359 · clinicaltrials.gov ↗

UNKNOWN

Status

138

Enrollment

OTHER

Sponsor class

Conditions

T2DM (Type 2 Diabetes Mellitus)
Diet, Healthy
Renal Function Disorder
Albuminuria

Interventions

DRUG: Sulfa-zero: possible benefits of the treatment of new generation hypoglycaemic drugs compared to sulphonylureas

Sponsor

University of Milan